Registro Completo |
Biblioteca(s): |
Biblioteca Rui Tendinha. |
Data corrente: |
01/08/2014 |
Data da última atualização: |
01/08/2014 |
Autoria: |
ODA, L. M. (Ed.). |
Afiliação: |
Leila Macedo Oda. |
Título: |
Biosafety of transgenic organisms in human health products. |
Ano de publicação: |
1996 |
Fonte/Imprenta: |
Rio de Janeiro, RJ : FIOCRUZ, 1996. |
Páginas: |
127 p. |
ISBN: |
85-85471-03-4 |
Idioma: |
Inglês |
Notas: |
Alguns capítulos em português. |
Conteúdo: |
A protocol on biosafety: Impacts on global development of biotechnology. An overview of health-related industrial biotechnology in Latim America and the Caribean. Drugs and Vaccines in evolution for new and old diseases. Development of yellow fever vaccine from infectious cDNA. Recombinant vaccines and biosafety. The challenge of using transgenic vaccines for major public health problems. Transgenic vaccine for big public health problems: Tuberculosis. Annex-Main biosafety regulations for BCG vaccine production. Cell Lines: Applications and biosafety. National and institutional biosafety committeesss. Paradigm biotenocientífico e paradigma bioético. |
Palavras-Chave: |
Biossegurança; Biotecnologia; Engenharia genética; Saúde pública; Transgênico; Vacina. |
Thesaurus NAL: |
Biosafety; Biotechnology; Genetic engeneering; Public health; Transgenics; Vaccine. |
Categoria do assunto: |
-- |
Marc: |
LEADER 01410nam a2200289 a 4500 001 1003859 005 2014-08-01 008 1996 bl uuuu 00u1 u #d 020 $a85-85471-03-4 100 1 $aODA, L. M. 245 $aBiosafety of transgenic organisms in human health products. 260 $aRio de Janeiro, RJ : FIOCRUZ$c1996 300 $a127 p. 500 $aAlguns capítulos em português. 520 $aA protocol on biosafety: Impacts on global development of biotechnology. An overview of health-related industrial biotechnology in Latim America and the Caribean. Drugs and Vaccines in evolution for new and old diseases. Development of yellow fever vaccine from infectious cDNA. Recombinant vaccines and biosafety. The challenge of using transgenic vaccines for major public health problems. Transgenic vaccine for big public health problems: Tuberculosis. Annex-Main biosafety regulations for BCG vaccine production. Cell Lines: Applications and biosafety. National and institutional biosafety committeesss. Paradigm biotenocientífico e paradigma bioético. 650 $aBiosafety 650 $aBiotechnology 650 $aGenetic engeneering 650 $aPublic health 650 $aTransgenics 650 $aVaccine 653 $aBiossegurança 653 $aBiotecnologia 653 $aEngenharia genética 653 $aSaúde pública 653 $aTransgênico 653 $aVacina
Download
Esconder MarcMostrar Marc Completo |
Registro original: |
Biblioteca Rui Tendinha (BRT) |